Literature DB >> 27363524

Prevalence of Entamoeba histolytica, Giardia lamblia, and Cryptosporidium spp. in Libya: 2000-2015.

Khalifa Sifaw Ghenghesh1, Khaled Ghanghish2, Elloulu T BenDarif3, Khaled Shembesh3, Ezzadin Franka3.   

Abstract

INTRODUCTION: The intestinal protozoa Entamoeba histolytica, Giardia lamblia, and Cryptosporidium spp. are the causative agents of giardiasis, amebiasis, and cryptosporidiosis, respectively. Adequate knowledge of the geographical distribution of parasites and the demographic variables that influence their prevalence is important for effective control of infection in at-risk populations.
METHODS: The data were obtained by an English language literature search of Medline and PubMed for papers using the search terms 'intestinal parasites and Libya, G. lamblia and Libya, E. histolytica and Libya and Cryptosporidium and Libya' for the period 2000-2015.
RESULTS: The data obtained for the period 2000-2015 showed prevalence rates of 0.8-36.6% (mean 19.9%) for E. histolytica/dispar, 1.2-18.2% (mean 4.6%) for G. lamblia and 0.9-13% (mean 3.4%) for Cryptosporidium spp. among individuals in Libya with gastroenteritis (GE). On the other hand, prevalence rates of 0.8-16.3% (mean 8.3%), 1.8-28.8% (mean 4.8%), and 1.0-2.5% (mean=2.4), respectively, were observed for individuals without GE. The mean prevalence rate of E. histolytica/dispar was significantly higher among individuals with GE compared with those without GE (p<0.0000001, OR=2.74). No significant difference in prevalence rate of the three organisms was found according to gender, but most of infections were observed in children aged 10 years or younger.
CONCLUSION: The reviewed data suggest that E. histolytica, G. lamblia, and Cryptosporidium spp. may play a minor role in GE in Libya. The observed high prevalence rates of E. histolytica/dispar reported from Libya could be due mainly to the non-pathogenic E. dispar and E. moshkovskii. However, more studies are needed in the future using E. histolytica-specific enzyme immunoassays and/or molecular methods to confirm this observation.

Entities:  

Keywords:  Cryptosporidium; Entamoeba histolytica; Giardia lamblia; Libya; gastroenteritis; intestinal protozoa

Mesh:

Year:  2016        PMID: 27363524      PMCID: PMC4929352          DOI: 10.3402/ljm.v11.32088

Source DB:  PubMed          Journal:  Libyan J Med        ISSN: 1819-6357            Impact factor:   1.657


Entamoeba histolytica, Giardia lamblia (synonymous with G. intestinalis and G. duodenalis), and Cryptosporidium spp. are the causative agents of amebiasis, giardiasis, and cryptosporidiosis, respectively. These organisms are among the most common intestinal protozoa associated with diarrhea in developed and developing countries (1, 2). The Global Burden of Disease Study (GBDS) estimated that amebiasis was associated with more than 55,000 deaths and 2.2 million disability-adjusted life years (DALYs), and cryptosporidiosis with more than 99,000 deaths and 8.3 million DALYs in 2010 (3, 4). Most of these deaths and DALYs occurred in developing countries. Table 1 shows reservoirs, modes of transmission, and clinical manifestations of E. histolytica, G. lamblia, and Cryptosporidium spp.
Table 1

Reservoirs, modes of transmission and clinical manifestations of Entamoeba histolytica, Giardia lamblia, and Cryptosporidium spp.

OrganismDiseaseReservoirMode of transmissionClinical manifestations
Entamoeba histolyticaAmebiasisInfected humansContaminated water, fecal–oral, contaminated foodDysentery (bloody diarrhea), diarrhea, intestinal, and/or liver abscesses
Giardia lambliaGiardiasisInfected human and other mammalsContaminated water, fecal–oralAcute and persistent diarrhea, bloating, gas, steatorrhea, and malabsorption
Cryptosporidium spp.CryptosporidiosisInfected human and a variety of animal hosts (zoonosis)Contaminated water, swimming pools, fecal–oralSelf-limited diarrhea; chronic diarrhea in immunocompromised individuals (e.g. AIDS)
Reservoirs, modes of transmission and clinical manifestations of Entamoeba histolytica, Giardia lamblia, and Cryptosporidium spp. Recently, Muhsen and Levine (5) carried out a systematic literature review investigating the correlation of G. lamblia infection with pediatric diarrhea in developing countries. Their findings indicate that giardiasis may not be associated with acute diarrhea in children, except in early infancy. However, their findings suggest that G. lamblia is positively correlated with persistent diarrhea in such populations. Adequate knowledge of the geographical distribution of parasites and the demographic variables that influence their prevalence is important for effective control of infection in at-risk populations (6). The aim of this mini-review is to report on E. histolytica, G. lamblia, and Cryptosporidium spp. in Libya for the period 2000−2015. The data were obtained by an English language literature search of Medline and PubMed for papers using the search terms ‘intestinal parasites and Libya, G. lamblia and Libya, E. histolytica and Libya, and Cryptosporidium and Libya’. Additional data were obtained from a Google search using the aforementioned terms. For statistical analysis, Epi Info 2000 software (Centers for Disease Control and Prevention) was employed. P-values were calculated using the Chi-square test. p<0.05 was considered to be statistically significant.

Prevalence of E. histolytica, G. lamblia, and Cryptosporidium spp. in people with or without gastroenteritis in Libya

The search of the published literature for the period 2000–2015 yielded seven studies that investigated stool samples only from individuals with gastroenteritis (GE, including some combination of diarrhea, abdominal pain, and vomiting) (7–13), eight studies only from individuals without GE (14–21), and one study from individuals with or without GE (22). Four studies that dealt with intestinal parasites in Libya were not included in this work. Two of the excluded studies were carried out in Benghazi, one of which examined stool specimens from diarrheic children during 1998–2002 and was published in 2002, and the other investigated persons without GE during 1998–1999 and was published in 2003 (23, 24). Also excluded was a study performed in 2006 in Tripoli and reporting results for 949 school children because the investigators examined only 591 stool samples (25). Moreover, a study performed in Benghazi between 1999 and 2000 on people of different nationalities was published in two different journals in 2004 (26) and 2005 (15), and so only the later study was included in this minireview. More than 90% of the studies (15 out of 16) included in this review used more than one technique of microscopic examination of stool samples for cysts of E. histolytica, G. lamblia, and Cryptosporidium. There are three species, among others, in the genus Entamoeba that can be found in the human intestine (27). These include the pathogenic E. histolytica and the nonpathogenic E. dispar and E. moshkovskii. The use of microscopy cannot distinguish E. histolytica from the latter two species. Unless stated otherwise, we use the term ‘E. histolytica/dispar’ because it was used in the majority of studies covered in this review. Of the GE studies, four examined stools from children and four examined stools from children and adults. These eight studies showed prevalence rates of 0.8–36.6% (mean 19.9%) for E. histolytica/dispar, 1.2–18.2% (mean 4.6%) for G. lamblia, and 0.9–13% (mean 3.4%) for Cryptosporidium spp. among individuals in Libya with GE. However, when only the data from children with GE were analyzed, the mean prevalence rate of E. histolytica/dispar dropped significantly from 19.9 to 4.0% (p<0.000001, odds ratio [OR] 5.96). No significant differences were observed in the mean prevalence rate of G. lamblia (3.2%) and of Cryptosporidium spp. (mean 4.2%) in children with GE compared with mean prevalence rates for both organisms in children and adults with GE. Table 2 shows the prevalence rates of E. histolytica/dispar, G. lamblia, and Cryptosporidium spp. in individuals with GE in different Libyan cities.
Table 2

Prevalence of Entamoeba histolytica/dispar, Giardia lamblia, and Cryptosporidium spp. in subjects with gastroenteritis* in different Libyan cities

No. positive/No. examined (%)

CityPopulation studiedEntamoeba histolytica/disparGiardia lambliaCryptosporidium spp.References
BrackChildren and adults29/305 (9.5)4/305 (1.3)7/305 (2.3)(7)
NaloutChildren and adults168/800 (21)20/800 (2.5)NE(8)
SirtChildren and adults323/700 (46.1)65/700 (9.3)NE(9)
SirtChildren128/350 (36.6)36/350 (10.3)NE(10)
Tripoli1Children4/110 (3.6)20/110 (18.2)1/110 (0.9)(22)
TripoliChildren2/239 (0.8)3/239 (1.3)5/239 (2.1)(11)
ZawiaChildren19/605 (3.1)11/605 (1.8)NE(12)
ZlitenChildren20/169 (11.8)2/169 (1.2)13/100 (13)(13)

Gastroenteritis=some combination of diarrhea, abdominal pain, and vomiting.

Tripoli and surrounding areas.

NE=Stool samples were not examined for Cryptosporidium spp.

Prevalence of Entamoeba histolytica/dispar, Giardia lamblia, and Cryptosporidium spp. in subjects with gastroenteritis* in different Libyan cities Gastroenteritis=some combination of diarrhea, abdominal pain, and vomiting. Tripoli and surrounding areas. NE=Stool samples were not examined for Cryptosporidium spp. Of the nine studies that examined individuals without GE, five included children, three included children and adults, and one study included adults only. The nine studies showed prevalence rates of 0.8–16.3% (mean 8.3%) for E. histolytica/dispar, 1.8–28.8% (mean 4.8%) for G. lamblia, and 1.0–2.5% (mean 2.4%) for Cryptosporidium spp. from individuals without GE. The mean prevalence rate of G. lamblia among children without GE (15.4%) was significantly higher than the mean prevalence rate of combined children and adults without GE (4.8%) (p<0.000001, OR 3.65). There was no significant difference between the mean prevalence rate of E. histolytica/ dispar among children (7.7%) and that in adults and children without GE combined (8.3%). A comparison of the mean prevalence rate of Cryptosporidium spp. among children and children and adults was not possible due to the small number of studies that examined the organism in stools of individuals without GE. Table 3 shows the prevalence of E. histolytica/dispar, G. lamblia, and Cryptosporidium spp. in people without GE in different Libyan cities and localities.
Table 3

Prevalence of Entamoeba histolytica/dispar, Giardia lamblia, and Cryptosporidium spp. in subjects without gastroenteritis* in different Libyan cities/localities

No. positive/No. examined (%)

CityPopulation studiedEntamoeba histolytica/disparGiardia lambliaCryptosporidium spp.References
AlkhomsChildren and adults289/2,383 (12.1)61/2,383 (2.6)NE(14)
BenghaziChildren and adults436/3,659 (11.9)109/3,659 (2.9)NE(15)
BenghaziAdults139/3,150 (4.4)60/3,150 (1.9)NE(16)
DernaChildren69/1,039 (6.6)132/1,039 (12.7)NE(17)
SirtChildren98/601 (16.3)173/601 (28.8)NE(18)
TripoliChildren2/50 (4.0)1/50 (2.0)NE(19)
TripoliChildren4/486 (0.8)28/486 (5.8)NE(20)
TripoliChildren3/100 (3.0)17/100 (17)1/100 (1.0)(22)
WadiAl-Shati localities1Children and adults14/1,192 (1.2)21/1,192 (1.8)30/1,192 (2.5)(21)

Gastroenteritis=Some combination of diarrhea, abdominal pain, and vomiting.

Stool samples were collected from 17 rural localities of Wadi Al-Shati in southwestern Libya.

NE=stool samples were not examined for Cryptosporidium spp.

Prevalence of Entamoeba histolytica/dispar, Giardia lamblia, and Cryptosporidium spp. in subjects without gastroenteritis* in different Libyan cities/localities Gastroenteritis=Some combination of diarrhea, abdominal pain, and vomiting. Stool samples were collected from 17 rural localities of Wadi Al-Shati in southwestern Libya. NE=stool samples were not examined for Cryptosporidium spp. A significantly higher mean prevalence rate of E. histolytica/dispar was found among children and adults with GE compared with the mean prevalence rate of E. histolytica/dispar in children and adults without GE (p<0.0000001, OR 2.74). On the other hand, significantly higher mean prevalence rates of E. histolytica/dispar and G. lamblia were found in children without GE compared with the mean prevalence rates of E. histolytica/dispar and G. lamblia in children with GE (p<00004, OR 2.02, and p<0.0000001, OR 5.51, respectively). High prevalence rates for E. histolytica/dispar and G. lamblia were reported mainly from the city of Sirt (Table 2 and 3), regardless of whether the individuals had or did not have GE.

Age, gender, and other factors associated with the prevalence of intestinal protozoa

Infections due to E. histolytica/dispar, G. lamblia, and Cryptosporidium spp. are prevalent in developing countries and depend on several factors, including age. Amebic infections mostly affect children below 15 years of age, with a significant increase in those aged five to nine years (28). In Arab countries, Cryptosporidium-associated diarrhea occurs mainly in younger children and inversely correlates with age, being more prevalent in children aged one year or less (29). Also, in developing countries, giardiasis is positively correlated with persistent diarrhea in children and with acute diarrhea in early infancy (5). On the other hand, no significant differences in the distribution of cases between males and females were reported from such countries. In Libya, a few studies examined the influence of age and gender on the prevalence of E. histolytica/dispar and G. lamblia, but none for Cryptosporidium spp. A study from Nalout in western Libya investigated children and adults with GE aged less than 10 years to more than 20 years for intestinal parasites (8). The researchers found that the prevalence rate of E. histolytica/dispar, but not G. lamblia, was significantly higher in children of less than 10 years compared with children of 10 to 20 years or more than 20 years of age. Nevertheless, they found no meaningful differences in the prevalence rates of the organisms among the examined children in regard to sex. Kasssem et al. (10) investigated the presence of intestinal parasites in children aged less than 16 years with GE in the city of Sirt. They detected 13 different intestinal protozoan parasites with the predominance of E. histolytica/dispar. The majority of E. histolytica/dispar and G. lamblia infections occurred in children 1–4 years old. However, no significant difference was observed in intestinal protozoa infection between male and female patients. Also, Alsirieti et al. (9) in Sirt city studied patients with GE aged 2–60 years. They reported intestinal parasites, including E. histolytica/dispar and G. lamblia, most commonly in those aged 2–10 years compared to other age groups, and higher infection rate in males than in females. Anuar et al. (30) carried out a cross-sectional study examining the prevalence and risk factors associated with E. histolytica/dispar/moshkovskii infection among different Orang Asli ethnic groups in Malaysia. They found higher prevalence rates among subjects aged less than 15 years. Furthermore, multivariate analysis proved that not washing subsequent to playing with soil or gardening and the presence of other family members infected with E. histolytica/dispar/moshkovskii were significant risk factors of infection among all groups examined. A study from the city of Sirt examined school children aged between 7 and 14 years without GE for factors associated with intestinal parasitic infection (18). The investigators found a statistically significant higher prevalence rates of E. histolytica/E. dispar among males than females, among those aged 7–10 years than those of 11–14 years, and among children who sometimes washed their hands than those who always washed their hands. The prevalence rates of E. histolytica/E. dispar among children with educated mothers were closely similar to those with non-educated mothers. They found no significant differences in the prevalence rate of G. lamblia between females and males, or between children 7–10 years old and those 11–14 years old. However, they observed statistically significant higher prevalence rates among children with non-educated mothers than those with educated mothers; and among children who sometimes washed their hands than children who always washed their hands. Another study, from Derna city, examined the presence of intestinal parasites in primary school children aged 6–12 years, selected by systematic random sampling using the master list of eight schools (17). They found no significant difference in the prevalence rates of E. histolytica/E. dispar and G. lamblia in relation to the gender and age of children. However, contrary to the study from Sirt, they found a significantly higher prevalence rate of intestinal parasites in children with educated than non-educated parents. In addition, they reported that children from lower income families, eating food from the school canteen and drinking water from metal tanks, were significantly associated with intestinal parasites, including E. histolytica/E. dispar and G. lamblia.

Prevalence of E. histolytica, G. lamblia, and Cryptosporidium spp. in food handlers and foreign workers

The main modes of transmission of intestinal protozoa are water- and food-borne. In general, there is lack of information regarding the prevalence of intestinal protozoa in water, fresh fruits, and vegetables in Libya. Only one study from Libya examined Giardia cysts in 126 specimens of fresh tomatoes, cucumber, lettuce, and cress from wholesale and retail markets in Tripoli. It reported a prevalence rate of 10% (31). None of the few reported outbreaks of amebiasis in developed countries were food-borne (32). There are no reports of outbreaks of amebiasis due to food handlers in developing countries. However, several food-borne outbreaks of cryptosporidiosis and giardiasis were attributed to direct contamination by food handlers (33). Kubti et al. (16) investigated 3,150 food handlers in Benghazi for intestinal parasites (1,563 Sudanese, 1,304 Egyptians, and 283 Libyans). The investigators found that the prevalence rate of E. histolytica/dispar among the Sudanese was significantly higher than among the Egyptian food handlers but not among the Libyan food handlers. On the other hand, the prevalence rate of G. lamblia was higher among the Egyptians than among the Sudanese and the Libyan food handlers, but the differences were not significant. A study from Alkhoms found a significantly higher prevalence rate of E. histolytica/dispar among foreign workers, mainly from Egypt and other African countries, than among Libyan individuals without GE. However, they observed a significantly higher prevalence rate of G. lamblia among Libyans compared with foreign workers.

Diagnosis of E. histolytica, G. lamblia, and Cryptosporidium spp. in subjects with or without gastrointestinal disturbances in Libya

The microscopic examination of stool specimens remains the backbone of the diagnosis of intestinal protozoa, particularly in developing countries. However, microscopic methods require well-trained medical technologists who can identify and differentiate pathogenic from non-pathogenic protozoa and discriminate artifacts. In Libya, there is a clear shortage of skilled technologists mainly due to a lack of training programs. In recent years, several enzyme immunoassays (EIAs) that detect antigens of E. histolytica, G. lamblia, and Cryptosporidium spp. in fresh or frozen stool specimens with 85−100% sensitivity and 93−100% specificity have become commercially available (34). Only one study in Libya used second-generation EIAs to investigate stool samples from diarrheic children in Tripoli (11). The investigators observed low prevalence rates of E. histolytica (0.8%), G. lamblia (1.3%), and Cryptosporidium spp. (2.1%). They reported that enteric viral and bacterial pathogens were significant causative agents of childhood diarrhea in Tripoli, but not the intestinal protozoa examined. Their findings contradict the high prevalence rates of E. histolytica/dispar reported by other studies from Libya using microscopy, particularly from the city of Sirt (Table 2 and 3). However, molecular studies have shown that many infections previously considered to be due to E. histolytica are caused by non-pathogenic E. dispar or E. moshkovskii (27). As mentioned previously, these three different species of Entamoeba cannot be differentiated by microscopy. Furthermore, a study from Saudi Arabia investigated 156 stool samples from diarrheic children for E. histolytica (35). The investigators detected E. histolytica/dispar in 65% of the samples by microscopy and in 2.6% of the samples by second generation E. histolytica-specific EIA. The authors concluded that the high prevalence of Entamoeba infections among the examined children was mainly due to E. dispar (i.e. E. dispar/E. moshkovskii). Therefore, the high prevalence rates of E. histolytica/dispar reported previously from Libya should be interpreted carefully.

Prevention and treatment

In developing countries, poor hygiene and the use of untreated human feces (i.e. fecal sludge) are important factors that contribute to the contamination of food and water. In such countries, prevention of infection with E. histolytica, G. lamblia, and Cryptosporidium spp. can be attained by improved community health education, sanitation, hygiene, and water treatment. To reduce enteric pathogens, including intestinal protozoa that may be present on fresh vegetables and fruits, the produce can be washed by clean tap water and soaked in a solution of acetic acid or vinegar for 10 to 15 minutes before consumption (36). Infected food handlers and caregivers in day-care centers and health institutions for the disabled and the elderly should be suspended from work for at least 3 months after completion of treatment with anti-parasitic agents. The nitroimidazoles (i.e. metronidazole, tinidazole, and ornidazole) are the drugs of choice for the treatment of amebiasis and giardiasis. More than a decade ago, the US Food and Drug Administration (FDA) approved nitazoxanide for the treatment of cryptosporidiosis in children and adults. Nitazoxanide is also effective against G. lamblia as well as other intestinal parasites.

Conclusion

The reviewed data suggest that E. histolytica, G. lamblia, and Cryptosporidium spp. may play a minor role in GE among the population in Libya and that infections occur mainly in children 10 years old or younger. In addition, the previously reported high prevalence rates of E. histolytica/dispar reported from Libya could have been due mainly to E. dispar and E. moshkovskii. However, more studies are needed using E. histolytica-specific EIAs and/or molecular methods (i.e. PCR) to confirm this observation. The use of such methods will stop unneeded drug therapy of patients infected with E. dispar, E. moshkovskii or both.
  20 in total

1.  Enteric pathogens associated with childhood diarrhea in Tripoli-Libya.

Authors:  Amal Rahouma; John D Klena; Zaineb Krema; Abdalwahed A Abobker; Khalid Treesh; Ezzedin Franka; Omar Abusnena; Hind I Shaheen; Hanan El Mohammady; Abdulhafid Abudher; Khalifa Sifaw Ghenghesh
Journal:  Am J Trop Med Hyg       Date:  2011-06       Impact factor: 2.345

Review 2.  Virulence and virulence factors in Entamoeba histolytica, the agent of human amoebiasis.

Authors:  Daniela M Faust; Nancy Guillen
Journal:  Microbes Infect       Date:  2012-06-16       Impact factor: 2.700

Review 3.  Enteric protozoa in the developed world: a public health perspective.

Authors:  Stephanie M Fletcher; Damien Stark; John Harkness; John Ellis
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

4.  Intestinal parasitosis in Nalout popularity, western Libya.

Authors:  M K Al Kilani; S M Dahesh; H A El Taweel
Journal:  J Egypt Soc Parasitol       Date:  2008-04

5.  Long term formalin preserved stool specimens for detection of intestinal parasites from school aged children in Tripoli, Libya.

Authors:  Najla A Ben Musa; R Ibrahim
Journal:  J Egypt Soc Parasitol       Date:  2007-12

Review 6.  Detection of intestinal protozoa in the clinical laboratory.

Authors:  Ian H McHardy; Max Wu; Robyn Shimizu-Cohen; Marc Roger Couturier; Romney M Humphries
Journal:  J Clin Microbiol       Date:  2013-11-06       Impact factor: 5.948

Review 7.  Reassessment of the epidemiology of amebiasis: state of the art.

Authors:  Cecilia Ximénez; Patricia Morán; Liliana Rojas; Alicia Valadez; Alejandro Gómez
Journal:  Infect Genet Evol       Date:  2009-06-18       Impact factor: 3.342

8.  Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.

Authors:  Christopher J L Murray; Theo Vos; Rafael Lozano; Mohsen Naghavi; Abraham D Flaxman; Catherine Michaud; Majid Ezzati; Kenji Shibuya; Joshua A Salomon; Safa Abdalla; Victor Aboyans; Jerry Abraham; Ilana Ackerman; Rakesh Aggarwal; Stephanie Y Ahn; Mohammed K Ali; Miriam Alvarado; H Ross Anderson; Laurie M Anderson; Kathryn G Andrews; Charles Atkinson; Larry M Baddour; Adil N Bahalim; Suzanne Barker-Collo; Lope H Barrero; David H Bartels; Maria-Gloria Basáñez; Amanda Baxter; Michelle L Bell; Emelia J Benjamin; Derrick Bennett; Eduardo Bernabé; Kavi Bhalla; Bishal Bhandari; Boris Bikbov; Aref Bin Abdulhak; Gretchen Birbeck; James A Black; Hannah Blencowe; Jed D Blore; Fiona Blyth; Ian Bolliger; Audrey Bonaventure; Soufiane Boufous; Rupert Bourne; Michel Boussinesq; Tasanee Braithwaite; Carol Brayne; Lisa Bridgett; Simon Brooker; Peter Brooks; Traolach S Brugha; Claire Bryan-Hancock; Chiara Bucello; Rachelle Buchbinder; Geoffrey Buckle; Christine M Budke; Michael Burch; Peter Burney; Roy Burstein; Bianca Calabria; Benjamin Campbell; Charles E Canter; Hélène Carabin; Jonathan Carapetis; Loreto Carmona; Claudia Cella; Fiona Charlson; Honglei Chen; Andrew Tai-Ann Cheng; David Chou; Sumeet S Chugh; Luc E Coffeng; Steven D Colan; Samantha Colquhoun; K Ellicott Colson; John Condon; Myles D Connor; Leslie T Cooper; Matthew Corriere; Monica Cortinovis; Karen Courville de Vaccaro; William Couser; Benjamin C Cowie; Michael H Criqui; Marita Cross; Kaustubh C Dabhadkar; Manu Dahiya; Nabila Dahodwala; James Damsere-Derry; Goodarz Danaei; Adrian Davis; Diego De Leo; Louisa Degenhardt; Robert Dellavalle; Allyne Delossantos; Julie Denenberg; Sarah Derrett; Don C Des Jarlais; Samath D Dharmaratne; Mukesh Dherani; Cesar Diaz-Torne; Helen Dolk; E Ray Dorsey; Tim Driscoll; Herbert Duber; Beth Ebel; Karen Edmond; Alexis Elbaz; Suad Eltahir Ali; Holly Erskine; Patricia J Erwin; Patricia Espindola; Stalin E Ewoigbokhan; Farshad Farzadfar; Valery Feigin; David T Felson; Alize Ferrari; Cleusa P Ferri; Eric M Fèvre; Mariel M Finucane; Seth Flaxman; Louise Flood; Kyle Foreman; Mohammad H Forouzanfar; Francis Gerry R Fowkes; Marlene Fransen; Michael K Freeman; Belinda J Gabbe; Sherine E Gabriel; Emmanuela Gakidou; Hammad A Ganatra; Bianca Garcia; Flavio Gaspari; Richard F Gillum; Gerhard Gmel; Diego Gonzalez-Medina; Richard Gosselin; Rebecca Grainger; Bridget Grant; Justina Groeger; Francis Guillemin; David Gunnell; Ramyani Gupta; Juanita Haagsma; Holly Hagan; Yara A Halasa; Wayne Hall; Diana Haring; Josep Maria Haro; James E Harrison; Rasmus Havmoeller; Roderick J Hay; Hideki Higashi; Catherine Hill; Bruno Hoen; Howard Hoffman; Peter J Hotez; Damian Hoy; John J Huang; Sydney E Ibeanusi; Kathryn H Jacobsen; Spencer L James; Deborah Jarvis; Rashmi Jasrasaria; Sudha Jayaraman; Nicole Johns; Jost B Jonas; Ganesan Karthikeyan; Nicholas Kassebaum; Norito Kawakami; Andre Keren; Jon-Paul Khoo; Charles H King; Lisa Marie Knowlton; Olive Kobusingye; Adofo Koranteng; Rita Krishnamurthi; Francine Laden; Ratilal Lalloo; Laura L Laslett; Tim Lathlean; Janet L Leasher; Yong Yi Lee; James Leigh; Daphna Levinson; Stephen S Lim; Elizabeth Limb; John Kent Lin; Michael Lipnick; Steven E Lipshultz; Wei Liu; Maria Loane; Summer Lockett Ohno; Ronan Lyons; Jacqueline Mabweijano; Michael F MacIntyre; Reza Malekzadeh; Leslie Mallinger; Sivabalan Manivannan; Wagner Marcenes; Lyn March; David J Margolis; Guy B Marks; Robin Marks; Akira Matsumori; Richard Matzopoulos; Bongani M Mayosi; John H McAnulty; Mary M McDermott; Neil McGill; John McGrath; Maria Elena Medina-Mora; Michele Meltzer; George A Mensah; Tony R Merriman; Ana-Claire Meyer; Valeria Miglioli; Matthew Miller; Ted R Miller; Philip B Mitchell; Charles Mock; Ana Olga Mocumbi; Terrie E Moffitt; Ali A Mokdad; Lorenzo Monasta; Marcella Montico; Maziar Moradi-Lakeh; Andrew Moran; Lidia Morawska; Rintaro Mori; Michele E Murdoch; Michael K Mwaniki; Kovin Naidoo; M Nathan Nair; Luigi Naldi; K M Venkat Narayan; Paul K Nelson; Robert G Nelson; Michael C Nevitt; Charles R Newton; Sandra Nolte; Paul Norman; Rosana Norman; Martin O'Donnell; Simon O'Hanlon; Casey Olives; Saad B Omer; Katrina Ortblad; Richard Osborne; Doruk Ozgediz; Andrew Page; Bishnu Pahari; Jeyaraj Durai Pandian; Andrea Panozo Rivero; Scott B Patten; Neil Pearce; Rogelio Perez Padilla; Fernando Perez-Ruiz; Norberto Perico; Konrad Pesudovs; David Phillips; Michael R Phillips; Kelsey Pierce; Sébastien Pion; Guilherme V Polanczyk; Suzanne Polinder; C Arden Pope; Svetlana Popova; Esteban Porrini; Farshad Pourmalek; Martin Prince; Rachel L Pullan; Kapa D Ramaiah; Dharani Ranganathan; Homie Razavi; Mathilda Regan; Jürgen T Rehm; David B Rein; Guiseppe Remuzzi; Kathryn Richardson; Frederick P Rivara; Thomas Roberts; Carolyn Robinson; Felipe Rodriguez De Leòn; Luca Ronfani; Robin Room; Lisa C Rosenfeld; Lesley Rushton; Ralph L Sacco; Sukanta Saha; Uchechukwu Sampson; Lidia Sanchez-Riera; Ella Sanman; David C Schwebel; James Graham Scott; Maria Segui-Gomez; Saeid Shahraz; Donald S Shepard; Hwashin Shin; Rupak Shivakoti; David Singh; Gitanjali M Singh; Jasvinder A Singh; Jessica Singleton; David A Sleet; Karen Sliwa; Emma Smith; Jennifer L Smith; Nicolas J C Stapelberg; Andrew Steer; Timothy Steiner; Wilma A Stolk; Lars Jacob Stovner; Christopher Sudfeld; Sana Syed; Giorgio Tamburlini; Mohammad Tavakkoli; Hugh R Taylor; Jennifer A Taylor; William J Taylor; Bernadette Thomas; W Murray Thomson; George D Thurston; Imad M Tleyjeh; Marcello Tonelli; Jeffrey A Towbin; Thomas Truelsen; Miltiadis K Tsilimbaris; Clotilde Ubeda; Eduardo A Undurraga; Marieke J van der Werf; Jim van Os; Monica S Vavilala; N Venketasubramanian; Mengru Wang; Wenzhi Wang; Kerrianne Watt; David J Weatherall; Martin A Weinstock; Robert Weintraub; Marc G Weisskopf; Myrna M Weissman; Richard A White; Harvey Whiteford; Natasha Wiebe; Steven T Wiersma; James D Wilkinson; Hywel C Williams; Sean R M Williams; Emma Witt; Frederick Wolfe; Anthony D Woolf; Sarah Wulf; Pon-Hsiu Yeh; Anita K M Zaidi; Zhi-Jie Zheng; David Zonies; Alan D Lopez; Mohammad A AlMazroa; Ziad A Memish
Journal:  Lancet       Date:  2012-12-15       Impact factor: 79.321

9.  Cryptosporidium in countries of the Arab world: the past decade (2002-2011).

Authors:  Khalifa Sifaw Ghenghesh; Khaled Ghanghish; Hanan El-Mohammady; Ezzddin Franka
Journal:  Libyan J Med       Date:  2012-11-27       Impact factor: 1.657

10.  Prevalence and risk factors associated with Entamoeba histolytica/dispar/moshkovskii infection among three Orang Asli ethnic groups in Malaysia.

Authors:  Tengku Shahrul Anuar; Hesham M Al-Mekhlafi; Mohamed Kamel Abdul Ghani; Emelia Osman; Azlin Mohd Yasin; Anisah Nordin; Siti Nor Azreen; Fatmah Md Salleh; Nuraffini Ghazali; Mekadina Bernadus; Norhayati Moktar
Journal:  PLoS One       Date:  2012-10-25       Impact factor: 3.240

View more
  9 in total

1.  Prevalence of Intestinal Parasites among Immunocompromised Patients, Children, and Adults in Sana'a, Yemen.

Authors:  Asma Al-Yousofi; Yongmin Yan; Abdulsalam M Al Mekhlafi; Kamal Hezam; Fatma A Abouelnazar; Balqees Al-Rateb; Hafsah Almamary; Rasheed Abdulwase
Journal:  J Trop Med       Date:  2022-06-08

Review 2.  Prevalence and Associated Risk Factors of Human Intestinal Protozoan Parasitic Infections in Ethiopia: A Systematic Review and Meta-Analysis.

Authors:  Dires Tegen; Destaw Damtie; Tamirat Hailegebriel
Journal:  J Parasitol Res       Date:  2020-10-05

3.  Development and Preliminary Application of a Triplex Real-Time Quantitative PCR Assay for the Simultaneous Detection of Entamoeba histolytica, Giardia lamblia, and Cryptosporidium parvum.

Authors:  Yaoguang Zhang; Jian Chen; Hao Pan; Xiaojiang Ma; Li Jiang; Qian Zhu; Huanyu Wu; Zhenyu Wang
Journal:  Front Microbiol       Date:  2022-04-28       Impact factor: 6.064

4.  Molecular Epidemiology of Giardia, Blastocystis and Cryptosporidium among Indigenous Children from the Colombian Amazon Basin.

Authors:  Angie Sánchez; Marina Munoz; Natalia Gómez; Juan Tabares; Laura Segura; Ángela Salazar; Cristian Restrepo; Miguel Ruíz; Patricia Reyes; Yuchen Qian; Lihua Xiao; Myriam C López; Juan D Ramírez
Journal:  Front Microbiol       Date:  2017-02-21       Impact factor: 5.640

5.  Entamoeba histolytica Induce Signaling via Raf/MEK/ERK for Neutrophil Extracellular Trap (NET) Formation.

Authors:  Zayda Fonseca; César Díaz-Godínez; Nancy Mora; Omar R Alemán; Eileen Uribe-Querol; Julio C Carrero; Carlos Rosales
Journal:  Front Cell Infect Microbiol       Date:  2018-07-04       Impact factor: 5.293

6.  Molecular Detection and Epidemiological Features of Selected Bacterial, Viral, and Parasitic Enteropathogens in Stool Specimens from Children with Acute Diarrhea in Thi-Qar Governorate, Iraq.

Authors:  Ali Harb; Sam Abraham; Bertha Rusdi; Tanya Laird; Mark O'Dea; Ihab Habib
Journal:  Int J Environ Res Public Health       Date:  2019-05-06       Impact factor: 3.390

7.  Prevalence, risk factors and seasonal variations of different Enteropathogens in Lebanese hospitalized children with acute gastroenteritis.

Authors:  Ali Salami; Hadi Fakih; Mohamed Chakkour; Lamis Salloum; Hisham F Bahmad; Ghassan Ghssein
Journal:  BMC Pediatr       Date:  2019-04-30       Impact factor: 2.125

8.  Intestinal protozoan infections among children 0-168 months with diarrhea in Mozambique: June 2014 - January 2018.

Authors:  Adilson Fernando Loforte Bauhofer; Idalécia Cossa-Moiane; Selma Marques; Esperança L Guimarães; Benilde Munlela; Elda Anapakala; Jorfélia J Chilaúle; Marta Cassocera; Jerónimo S Langa; Assucênio Chissaque; Júlia Sambo; Lena Manhique-Coutinho; Diocreciano Matias Bero; Timothy A Kellogg; Nilsa de Deus
Journal:  PLoS Negl Trop Dis       Date:  2020-04-22

9.  Trend Analysis of Intestinal Parasitic Infections at Debre Tabor Comprehensive Specialized Hospital, Northwest Ethiopia from 2017 to 2021: A Five-Year Retrospective Study.

Authors:  Lemma Workineh; Andargachew Almaw; Tahir Eyayu
Journal:  Infect Drug Resist       Date:  2022-03-10       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.